JP7735624B2 - 推論装置、推論方法、推論プログラム、モデル生成方法、推論サービス提供システム、推論サービス提供方法及び推論サービス提供プログラム - Google Patents

推論装置、推論方法、推論プログラム、モデル生成方法、推論サービス提供システム、推論サービス提供方法及び推論サービス提供プログラム

Info

Publication number
JP7735624B2
JP7735624B2 JP2022545756A JP2022545756A JP7735624B2 JP 7735624 B2 JP7735624 B2 JP 7735624B2 JP 2022545756 A JP2022545756 A JP 2022545756A JP 2022545756 A JP2022545756 A JP 2022545756A JP 7735624 B2 JP7735624 B2 JP 7735624B2
Authority
JP
Japan
Prior art keywords
lipid molecules
chemical structure
structure information
input data
inference
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2022545756A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2022045334A1 (https=
Inventor
友大 前田
臨 小川
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical Co Ltd filed Critical Takeda Pharmaceutical Co Ltd
Publication of JPWO2022045334A1 publication Critical patent/JPWO2022045334A1/ja
Application granted granted Critical
Publication of JP7735624B2 publication Critical patent/JP7735624B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16CCOMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C20/00Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
    • G16C20/30Prediction of properties of chemical compounds, compositions or mixtures
    • GPHYSICS
    • G06COMPUTING OR CALCULATING; COUNTING
    • G06NCOMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N20/00Machine learning
    • G06N20/20Ensemble learning
    • GPHYSICS
    • G06COMPUTING OR CALCULATING; COUNTING
    • G06NCOMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N3/00Computing arrangements based on biological models
    • G06N3/004Artificial life, i.e. computing arrangements simulating life
    • G06N3/006Artificial life, i.e. computing arrangements simulating life based on simulated virtual individual or collective life forms, e.g. social simulations or particle swarm optimisation [PSO]
    • GPHYSICS
    • G06COMPUTING OR CALCULATING; COUNTING
    • G06NCOMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N5/00Computing arrangements using knowledge-based models
    • G06N5/01Dynamic search techniques; Heuristics; Dynamic trees; Branch-and-bound
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16CCOMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C20/00Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
    • G16C20/70Machine learning, data mining or chemometrics

Landscapes

  • Engineering & Computer Science (AREA)
  • Theoretical Computer Science (AREA)
  • Computing Systems (AREA)
  • Software Systems (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Artificial Intelligence (AREA)
  • Data Mining & Analysis (AREA)
  • Evolutionary Computation (AREA)
  • Physics & Mathematics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Mathematical Physics (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Health & Medical Sciences (AREA)
  • Computational Linguistics (AREA)
  • Databases & Information Systems (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2022545756A 2020-08-31 2021-08-30 推論装置、推論方法、推論プログラム、モデル生成方法、推論サービス提供システム、推論サービス提供方法及び推論サービス提供プログラム Active JP7735624B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020146402 2020-08-31
JP2020146402 2020-08-31
PCT/JP2021/031711 WO2022045334A1 (ja) 2020-08-31 2021-08-30 推論装置、推論方法、推論プログラム、モデル生成方法、推論サービス提供システム、推論サービス提供方法及び推論サービス提供プログラム

Publications (2)

Publication Number Publication Date
JPWO2022045334A1 JPWO2022045334A1 (https=) 2022-03-03
JP7735624B2 true JP7735624B2 (ja) 2025-09-09

Family

ID=80353466

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022545756A Active JP7735624B2 (ja) 2020-08-31 2021-08-30 推論装置、推論方法、推論プログラム、モデル生成方法、推論サービス提供システム、推論サービス提供方法及び推論サービス提供プログラム

Country Status (5)

Country Link
US (1) US20240038340A1 (https=)
EP (1) EP4207205A4 (https=)
JP (1) JP7735624B2 (https=)
CN (1) CN115989511A (https=)
WO (1) WO2022045334A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2023190974A1 (https=) * 2022-03-31 2023-10-05
US12587274B2 (en) 2023-03-28 2026-03-24 Quantum Generative Materials Llc Satellite optimization management system based on natural language input and artificial intelligence
KR102763227B1 (ko) * 2023-09-26 2025-02-07 주식회사 그래디언트바이오컨버전스 최적의 줄기 세포 배양배지 조합 결정 장치, 배양배지 조합들에 대한 분화 성공률을 산출하여 최적의 조합을 결정하는 방법, 및 컴퓨터 프로그램
KR102763225B1 (ko) * 2023-09-26 2025-02-07 주식회사 그래디언트바이오컨버전스 최적의 오가노이드 배양배지 조합 결정 장치, 배양배지 조합들에 대한 생존율을 산출하여 최적의 조합을 결정하는 방법, 및 컴퓨터 프로그램
KR102753534B1 (ko) * 2023-10-24 2025-01-14 주식회사 그래디언트바이오컨버전스 최적의 줄기 세포 배양배지 조합 결정 장치, 배양배지 조합들에 대한 유전자 발현량을 산출하여 최적의 조합을 결정하는 방법, 및 컴퓨터 프로그램
US12368503B2 (en) 2023-12-27 2025-07-22 Quantum Generative Materials Llc Intent-based satellite transmit management based on preexisting historical location and machine learning
US12603701B2 (en) 2023-12-27 2026-04-14 Quantum Generative Materials Llc Distributed satellite constellation management and control system

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005530771A (ja) 2002-05-08 2005-10-13 ユニバーシティ カレッジ ロンドン 生物学的活性物質の細胞への運搬に適した複合体
JP2019515913A (ja) 2016-04-22 2019-06-13 科済生物医薬(上海)有限公司Carsgen Therapeutics Limited 細胞免疫療法の組成物および方法
WO2020031671A1 (ja) 2018-08-08 2020-02-13 パナソニックIpマネジメント株式会社 材料記述子生成方法、材料記述子生成装置、材料記述子生成プログラム、予測モデル構築方法、予測モデル構築装置及び予測モデル構築プログラム

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4370591B2 (ja) * 2001-07-31 2009-11-25 独立行政法人産業技術総合研究所 リポソームおよびそれからなる細胞への物質導入担体
US7598421B2 (en) * 2002-05-08 2009-10-06 Ucl Biomedica Plc Materials for the delivery of biologically-active material to cells
WO2012119129A1 (en) * 2011-03-02 2012-09-07 Berg Biosystems, Llc Interrogatory cell-based assays and uses thereof
MX375673B (es) * 2012-04-02 2025-03-06 Berg Llc Ensayos basados en interrogatorios celulares y usos de los mismos.
WO2015138309A1 (en) * 2014-03-13 2015-09-17 Dana-Farber Cancer Institute, Inc. Compositions and methods for regulating pancreatic beta cell function using adipsin
WO2016021683A1 (ja) 2014-08-07 2016-02-11 武田薬品工業株式会社 カチオン性脂質
CN104561067A (zh) * 2014-12-24 2015-04-29 广东省人民医院 一种安全高效的蛋白质转染进入细胞的载体
CN110418636A (zh) * 2016-08-23 2019-11-05 杰罗米.J.申塔格 将肽、蛋白质和核酸负载至乳糜微粒和体细胞中的胆固醇酯囊泡
WO2019010384A1 (en) * 2017-07-07 2019-01-10 The Broad Institute, Inc. METHODS FOR DESIGNING GUIDE SEQUENCES FOR GUIDED NUCLEASES
TWI802627B (zh) 2017-12-28 2023-05-21 日商武田藥品工業股份有限公司 陽離子性脂質
DK3835287T3 (da) 2018-08-10 2025-01-02 Takeda Pharmaceuticals Co Kationisk lipid
JP7240210B2 (ja) 2019-03-15 2023-03-15 トヨタホーム株式会社 宅配ボックスシステム

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005530771A (ja) 2002-05-08 2005-10-13 ユニバーシティ カレッジ ロンドン 生物学的活性物質の細胞への運搬に適した複合体
JP2019515913A (ja) 2016-04-22 2019-06-13 科済生物医薬(上海)有限公司Carsgen Therapeutics Limited 細胞免疫療法の組成物および方法
WO2020031671A1 (ja) 2018-08-08 2020-02-13 パナソニックIpマネジメント株式会社 材料記述子生成方法、材料記述子生成装置、材料記述子生成プログラム、予測モデル構築方法、予測モデル構築装置及び予測モデル構築プログラム

Also Published As

Publication number Publication date
JPWO2022045334A1 (https=) 2022-03-03
CN115989511A (zh) 2023-04-18
EP4207205A4 (en) 2025-02-26
EP4207205A1 (en) 2023-07-05
US20240038340A1 (en) 2024-02-01
WO2022045334A1 (ja) 2022-03-03

Similar Documents

Publication Publication Date Title
JP7735624B2 (ja) 推論装置、推論方法、推論プログラム、モデル生成方法、推論サービス提供システム、推論サービス提供方法及び推論サービス提供プログラム
Sun et al. Spatial transcriptomic clocks reveal cell proximity effects in brain ageing
Kalmbach et al. Signature morpho-electric, transcriptomic, and dendritic properties of human layer 5 neocortical pyramidal neurons
Hoy Onasemnogene abeparvovec: first global approval
Wallace et al. Survival of midbrain dopaminergic cells after lesion or deep brain stimulation of the subthalamic nucleus in MPTP-treated monkeys
Sadekar et al. Translational approaches for brain delivery of biologics via cerebrospinal fluid
Wang et al. Allopregnanolone reverses neurogenic and cognitive deficits in mouse model of Alzheimer's disease
Lennon et al. Dysferlin interacts with annexins A1 and A2 and mediates sarcolemmal wound-healing
Sandberg et al. Regional and strain-specific gene expression mapping in the adult mouse brain
Liu et al. Cm-siRPred: Predicting chemically modified siRNA efficiency based on multi-view learning strategy
Ellegood et al. Neuroanatomical assessment of the integrin β3 mouse model related to autism and the serotonin system using high resolution MRI
JP2022520009A (ja) Nmda、グリシンおよびampa受容体のモジュレーターの薬理ゲノミクス決定支援
Biliouris et al. A semi‐mechanistic population pharmacokinetic model of nusinersen: an antisense oligonucleotide for the treatment of spinal muscular atrophy
Coleman Linking radiation oncology and imaging through molecular biology (or now that therapy and diagnosis have separated, it’s time to get together again!)
CN108271422A (zh) 基于器官间串扰系统的预测装置及预测程序
CN118588226B (zh) 抗癫痫药用药策略优化模型的训练方法、优化方法及装置
Kawalia et al. Analytical strategy to prioritize Alzheimer’s disease candidate genes in gene regulatory networks using public expression data
CN118039062A (zh) 一种基于大数据分析的个体化化疗剂量远程控制方法
JP6737519B1 (ja) プログラム、学習モデル、情報処理装置、情報処理方法および学習モデルの生成方法
Eder et al. Exercise-induced CITED4 expression is necessary for regional remodeling of cardiac microstructural tissue helicity
EP4489009A1 (en) Inference device, generation device, inference program, and generation program
Sun et al. Seizure sources can be imaged from scalp EEG by means of biophysically constrained deep neural networks
Blanzieri et al. A computing system for discovering causal relationships among human genes to improve drug repositioning
Phielipp et al. Investigational Gene Therapies for Parkinson's Disease: N. Phielipp et al.
Smith et al. Naturally occurring hypertension in New World nonhuman primates: potential role of the perifornical hypothalamus

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20230207

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240502

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250311

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250425

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20250729

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20250801

R150 Certificate of patent or registration of utility model

Ref document number: 7735624

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150